Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

OPC-1085

Known as: OPC 1085, OPC1085 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1978
1978
Cardiac electrophysiologic action of a new beta-adrenergic blocking agent carteolol hydrochloride, or OPC-1085, was studied in… Expand
Is this relevant?
1977
1977
The pharmacokinetics of 5-(3-tert.-butylamino-2-hydroxy)-propoxy-3,4-dihydrocarbostyril hydrochloride (carteolol hydrochloride… Expand
Is this relevant?
1977
1977
The kinetics (absorption, distribution and excretion) of carteolol were investigated after oral and intravenous administration to… Expand
Is this relevant?
1977
1977
Effects of a newly synthesized beta-blocker, 5-(3-tert-butylamino-2-hydroxy) propoxy-3,4-dihydrocarbostyril (OPC-1085) were… Expand
Is this relevant?
1977
1977
The effects of carteolol, propranolol and alprenolol were studied by using spontaneously contracting atria, atrial muscle and… Expand
Is this relevant?
1977
1977
1. The antiarrhythmic properties of 5-(3-tert-butylamino-2-hydroxy)propoxy-3,4-dihydrocarbostyril hydrochloride (opc-1085) were… Expand
Is this relevant?
1976
1976
Distribution of a new beta-adrenergic blocking agent, 3H-carteolol in mice was studied by whole body autoradiography. The… Expand
Is this relevant?
1976
1976
新β-遮断薬3H-carteololはマウス静脈内または経口投与した場合比較的早期に眼および脳を除きほぼ全臓器に分布し,特に腎臓,肝臓,胆嚢および小腸内容中に高い放射活性がみられた.その後速やかに各組織より消失し,投与された3H-carteolol… Expand
Is this relevant?
1975
1975
Effects of a new beta-adrenergic blocking agent, 5-(3-tert-butylamino-2-hydroxy) propoxy-3,4-dihydrocarbostyril hydrochloride… Expand
Is this relevant?
1974
1974
The beta-adrenergic blocking and hemodynamic properties of 5-(3-tert-butyl-amino-2-hydroxy) propoxy-3,4-dihydrocarbostyril… Expand
Is this relevant?